International Journal of Drug Delivery Technology
Volume 14, Issue 1

UFLC Method Development and Validation for Anti-retroviral Drugs, Investigation of Greenness Assessment using Complex GAPI, AGREE and AMGS SPREADSHEET

Bommaiah P Kumar*, Toppada Y Pasha

Department of Pharmaceutical Analysis, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, Mandya, Karnataka, India

Received: 15th January, 2024; Revised: 11th February, 2024; Accepted: 25th February, 2024; Available Online: 25th March, 2024

ABSTRACT

Introduction: The study’s proposal was to establish a method of development and validation by green chromatography technique for antiviral drugs, as well as to assess the proposed method’s greenness using various tools, which is one of the emerging developments in the analytical field. The chromatographic separation is achieved by using Eclipse plus C18 (250 x 4.6, 5 μm) column by applying isocratic elution using the mobile phase containing methanol and isopropyl acetate in the ratio of (60:40% v/v) with 1-mL/min flow rate. The separation of drugs is achieved by using a greener mobile phase.

Results: The retention time of ritonavir and ombitasvir was found to be 1.854 and 8.09 minutes, respectively. The regression coefficient (R2) is 0.997 for both drugs. Accuracy and precision is evaluated for the method and found be within the limit and the results were reproducible. Assessment of the method was carried out using the three different tools. The developed method is anticipated to be eco-friendly, an alternative to the developed method HPLC method in regard to safe solvent, less toxic and less run time. The developed method was found suitable for the simultaneous estimation in their combined dosage form.

Keywords: Antiviral drugs, Green chromatography, UFLC, Complex GAPI, AGREE, AMGS. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.52

How to cite this article: Kumar BP, Pasha TY. UFLC Method Development and Validation for Anti-retroviral Drugs, Investigation of Greenness Assessment using Complex GAPI, AGREE and AMGS SPREADSHEET. International Journal of Drug Delivery Technology. 2024;14(1):360-366.

REFERENCES

  1. Wu J, Huang P, Fan H, Tian T, Xia X, Fu Z, Wang Y, Ye X, Yue M, Zhang Y. Effectiveness of ombitasvir/paritaprevir/ ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis. Virology journal. 2019 Dec;16:1-0.
  2. Badri PS, Shuster DL, Dutta S, Menon Clinical pharmacokinetics of ombitasvir. Clinical pharmacokinetics. 2017 Oct;56:1103-13.
  3. Imam MS, Batubara AS, Gamal M, Abdelazim AH, Almrasy AA, Ramzy Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations. Scientific Reports. 2023 Jan 4;13(1):137.
  4. Saraya RE, Salman BI, Batakoushi H, Elgamal M. Review article on instrumental analysis of Molnupiravir, Favipiravir, and Ritonavir in different Octahedron Drug Research. 2023 Jan 1;2(1):36-43.
  5. Wanounou M, Caraco Y, Levy RH, Bialer M, Perucca E. Clinically relevant interactions between ritonavir-boosted nirmatrelvir and concomitant antiseizure medications: implications for the management of COVID-19 in patients with epilepsy. Clinical pharmacokinetics. 2022 Sep;61(9):1219-36.
  6. Ibrahim AE, Saraya RE, Saleh H, Elhenawee M. Development and validation of eco-friendly micellar-HPLC and HPTLC- densitometry methods for the simultaneous determination of paritaprevir, ritonavir and ombitasvir in pharmaceutical dosage forms. Heliyon. 2019 Apr 1;5(4).
  7. Płotka J, Tobiszewski M, Sulej AM, Kupska M, Górecki T, Namieśnik Green chromatography. Journal of Chromatography2013 Sep 13;1307:1-20.
  8. El-Yazbi AF, Elashkar NE, Ahmed HM, Talaat W, Abdel-Hay KM. Cost-effective green chromatographic method for the simultaneous determination of four commonly used direct- acting antiviral drugs in plasma and various pharmaceutical formulations. Microchemical Journal. 2021 Sep 1;168:106512.
  9. Gałuszka A, Migaszewski ZM, Konieczka P, Namieśnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trends in Analytical Chemistry. 2012 Jul 1;37:61-72.
  10. Saraya RE, Deeb SE, Salman BI, Ibrahim AE. Highly sensitive high‐performance thin‐layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical Journal of separation science. 2022 Jul;45(14):2582-90.
  11. Armenta S, Esteve-Turrillas FA, Garrigues S, de la Guardia Green Analytical Chemistry: concepts, evolution, and recent developments. Green Approaches for Chemical Analysis. 2023 Jan 1:1-37.
  12. Pappula N, Narla D. Development and validation of stability indicating uhplc method for simultaneous estimation of ombitasvir, paritaprevir and ritonavir in pharmaceutical dosage forms. Research Journal of Pharmacy and Technology. 2022;15(3):1307-12.
  13. Wojnowski W, Tobiszewski M, Pena-Pereira F, Psillakis E. AGREEprep–analytical greenness metric for sample preparation. TrAC Trends in Analytical 2022 Apr 1;149:116553.
  14. Płotka-Wasylka J, Wojnowski W. Complementary green analytical procedure index (ComplexGAPI) and Green Chemistry. 2021;23(21):8657-65.
  15. Imam MS, Batubara AS, Gamal M, Abdelazim AH, Almrasy AA, Ramzy Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations. Scientific Reports. 2023 Jan 4;13(1):137.
  16. Mohamed HM, Saad AS, Morsi AM, Essam Green RP-HPLC method for simultaneous determination of sofosbuvir, ledipasvir, velpatasvir antivirals and beyond in their bulk material and co-formulated products. Microchemical Journal. 2023 Mar 1;186:108344.